脱氢醋酸钠
Sodium dehydroacetate;2-ACETYL-5-HYDROXY-3-OXO-4-HEXENOIC ACID DELTA-LACTONE SODIUM SALT;2-ACETYL-5-HYDROXY-3-OXO-4-HEXENOIC ACID GAMMA-LACTONE SODIUM SALT;3-(1-hydroxyethylidene)-6-methyl-2H-pyran-2,4(3H)-dione sodium salt;3-ACETYL-4-HYDROXY-6-METHYL-2-PYRONE SODIUM SALT;3-ACETYL-6-METHYL-2H-PYRAN-2,4(3H)-DIONE SODIUM SALT;acetyl-6-methyl-2h-pyran-2,4(3h)-dione sodium;DEHYDROACETIC ACID SODIUM SALT;Sodium 1-(3,4-dihydro-6-methyl-2,4-dioxo-2H-pyran-3-ylidene)ethanolate;SODIUM 3-ACETYL-4-HYDROXY-6-METHYL-2-OXO-4(2H)-PYRANOLATE;2H-Pyran-2,4(3H)-dione,3-acetyl-6-methyl-,ion(1-),sodium;3-(1-hydroxyethylidene)-6-methyl-2h-pyran-2,4(3h)-dione,sodiumsalt[qr];4(3h)-dione,3-acetyl-6-methyl-2h-pyran-sodiumsalt;4(3h)-dione,3-acetyl-6-methyl-2h-pyran-sodiumsalt[qr];4-hexenoicacid,2-acetyl-5-hydroxy-3-oxo,delta-lactone,sodiumderiv.;dehydroacetic;dehydroaceticacid,sodiumsalt[qr];dha-sodium;dhn;2-Acetyl-5-hydroxy-3-oxo-4-hexenoic acid δ-lactone sodium salt;harven;NaDHA;New Side S 01;prevan;Sodium dehydroacetat;Sodium Dehydroacetic Acid;Dehydroacetic acid sodium salt, >=98.0% (NT);418H262;2-Acetyl-5-hydroxy-3-oxo-4-hexenoic acid I -lactone sodium salt;Sodium Dehydroacetic Acid, Pharmaceutical Secondary Standard; Certified Reference Material;3-Acetyl-4-hydroxy-6-methylpyran-2-one;sodium;Dehydroacetic acid sodium;Acetyl-6-methyl-2H-pyran-2,4(3H)-dione sodium;SODIUM DEHYDROACETATE